Alzheimer’s Drug Discovery Foundation Chief Executive Officer Mark Roithmayr Announces Retirement in 2025
Hand-out
Press Releases

Alzheimer’s Drug Discovery Foundation Chief Executive Officer Mark Roithmayr Announces Retirement in 2025

NEW YORK, April 24, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that Mark Roithmayr will retire from his role as Chief Executive Officer effective December 31,

avatar profile Olean Times Herald

Olean Times Herald


Local & Social